Literature DB >> 30484180

Retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab for carcinoma of the buccal mucosa with N3 lymph node metastasis: a case report.

Kaname Sakuma1,2, Toshiyuki Koizumi3, Kenji Mitsudo1, Jun Ueda2, Yuichiro Hayashi1, Toshinori Iwai1, Makoto Hirota1, Mitomu Kioi1, Haruka Yoshii1, Hisashi Kaizu4, Masaharu Hata4, Akira Tanaka5, Iwai Tohnai1.   

Abstract

We herein report a case of squamous cell carcinoma of the buccal mucosa with N3 cervical lymph node metastasis in a 63-year-old man. The patient was treated with combination therapy comprising radiotherapy (2 Gy/day, total of 70 Gy), superselective intra-arterial chemotherapy via a superficial temporal artery (docetaxel, total of 70 mg/m2 and cisplatin, total of 175 mg/m2), cetuximab (initial dose of 400 mg/m2 with subsequent weekly doses of 250 mg/m2 intravenously), and four sessions of hyperthermia for cervical lymph node metastases. The patient responded well to the therapy, with a complete response of the primary tumor. Radical neck dissection was performed with reconstructive surgery, including resection of the overlying skin. A pathologic complete response was achieved for the N3 and all other cervical lymph node metastases. The patient showed no evidence of recurrence in the 3 years following treatment. Based on the findings in the present case, the use of retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab seems to be a promising modality for patients with N3 cervical lymph node metastasis of oral cancer.

Entities:  

Keywords:  Cetuximab; Hyperthermia; Intra-arterial chemoradiotherapy; N3 cervical lymph node metastasis; Oral cancer

Mesh:

Substances:

Year:  2018        PMID: 30484180     DOI: 10.1007/s11282-018-0319-y

Source DB:  PubMed          Journal:  Oral Radiol        ISSN: 0911-6028            Impact factor:   1.852


  19 in total

1.  Organ preservation with daily concurrent chemoradiotherapy using superselective intra-arterial infusion via a superficial temporal artery for T3 and T4 head and neck cancer.

Authors:  Kenji Mitsudo; Toshio Shigetomi; Yasushi Fujimoto; Hiroaki Nishiguchi; Noriyuki Yamamoto; Hiroki Furue; Minoru Ueda; Yoshiyuki Itoh; Nobukazu Fuwa; Iwai Tohnai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-06-03       Impact factor: 7.038

2.  Retrograde superselective intra-arterial chemotherapy and daily concurrent radiotherapy for stage III and IV oral cancer: analysis of therapeutic results in 112 cases.

Authors:  Kenji Mitsudo; Toshiyuki Koizumi; Masaki Iida; Toshinori Iwai; Hideyuki Nakashima; Senri Oguri; Mitomu Kioi; Makoto Hirota; Izumi Koike; Masaharu Hata; Iwai Tohnai
Journal:  Radiother Oncol       Date:  2014-04-17       Impact factor: 6.280

3.  Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.

Authors:  M L Gillison; W M Koch; R B Capone; M Spafford; W H Westra; L Wu; M L Zahurak; R W Daniel; M Viglione; D E Symer; K V Shah; D Sidransky
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

4.  Thermochemoradiation therapy using superselective intra-arterial infusion via superficial temporal and occipital arteries for oral cancer with N3 cervical lymph node metastases.

Authors:  Kenji Mitsudo; Toshiyuki Koizumi; Masaki Iida; Toshinori Iwai; Senri Oguri; Noriyuki Yamamoto; Yoshiyuki Itoh; Mitomu Kioi; Makoto Hirota; Iwai Tohnai
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-04-28       Impact factor: 7.038

5.  A combination therapy of continuous superselective intraarterial carboplatin infusion and radiation therapy for locally advanced head and neck carcinoma. Phase I study.

Authors:  N Fuwa; Y Ito; A Matsumoto; M Kamata; T Kodaira; K Furutani; M Sasaoka; Y Kimura; K Morita
Journal:  Cancer       Date:  2000-11-15       Impact factor: 6.860

6.  Efficacy of adjuvant chemotherapy for patients with resectable head and neck cancer: a subset analysis of the Head and Neck Contracts Program.

Authors:  C Jacobs; R Makuch
Journal:  J Clin Oncol       Date:  1990-05       Impact factor: 44.544

7.  Platinum-based chemotherapy plus cetuximab in head and neck cancer.

Authors:  Jan B Vermorken; Ricard Mesia; Fernando Rivera; Eva Remenar; Andrzej Kawecki; Sylvie Rottey; Jozsef Erfan; Dmytro Zabolotnyy; Heinz-Roland Kienzer; Didier Cupissol; Frederic Peyrade; Marco Benasso; Ihor Vynnychenko; Dominique De Raucourt; Carsten Bokemeyer; Armin Schueler; Nadia Amellal; Ricardo Hitt
Journal:  N Engl J Med       Date:  2008-09-11       Impact factor: 91.245

8.  Hyperthermia adds to chemotherapy.

Authors:  Rolf D Issels
Journal:  Eur J Cancer       Date:  2008-09-11       Impact factor: 9.162

9.  HPV16 infection in oral cavity and oropharyngeal cancer patients.

Authors:  Juliet Dang; Qinghua Feng
Journal:  J Oral Sci       Date:  2016       Impact factor: 1.556

10.  Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.

Authors:  Carole Fakhry; William H Westra; Sigui Li; Anthony Cmelak; John A Ridge; Harlan Pinto; Arlene Forastiere; Maura L Gillison
Journal:  J Natl Cancer Inst       Date:  2008-02-12       Impact factor: 13.506

View more
  2 in total

Review 1.  Systematic review about complementary medical hyperthermia in oncology.

Authors:  Christina Maria Liebl; Sabine Kutschan; Jennifer Dörfler; Lukas Käsmann; Jutta Hübner
Journal:  Clin Exp Med       Date:  2022-06-29       Impact factor: 5.057

2.  Efficacy and Safety of Intro-Arterial Chemotherapy Combined with Radiotherapy on Head and Neck Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yan Huang; Li-Ling Wu; Ruo-Lan Xiang; Guang-Yan Yu
Journal:  J Cancer       Date:  2019-10-17       Impact factor: 4.207

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.